COMPARATIVE INHIBITION OF HIV REPLICATION BY NYSTATIN A
制霉菌素 A 对 HIV 复制的比较抑制作用
基本信息
- 批准号:3804859
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Nystatin A, a poly macrolide antifungal antibiotic to HIV replication in H9
cells was examined and compared to amphotericin B and Foscarnet. H9 cells
were absorbed with infectious HIV for two hours and were then exposed to
various concentrations and combinations of the above agents for days.
After 7 days the cultures were tested for reverse transcriptase and p24
antigen in culture cell and supernatents. The results suggest that
Nystatin A was an effective antiviral agent at a concentration that was
relatively nontoxic to the cells. The most effective concentration of 10
ug/culture fluid. In comparison with amphotericin B and Foscarnet,
Nystatin A demonstrated 95% inhibition of RT activity and 90% inhibition of
p24 antigen production. Furthermore, no virus antigen could be detected
using western blotting techniques.
Future experiments will focus on using immunoliposomes to specifically
deliver these agents to target cells.
制霉菌素A,一种多环内酯类抗真菌抗生素,可抑制HIV在H9病毒中的复制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M P SELVAM其他文献
M P SELVAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M P SELVAM', 18)}}的其他基金
ANTIBODY DEPENDENT COMPLEMENT MEDIATED KILLING OF HIV-2 INFECTED CELLS
抗体依赖性补体介导杀死 HIV-2 感染细胞
- 批准号:
5200826 - 财政年份:
- 资助金额:
-- - 项目类别:
HIV-PROTEASE INHIBITORS AND ANTIBIOTICS AS ANTIVIRALS
HIV 蛋白酶抑制剂和抗生素作为抗病毒药
- 批准号:
3770417 - 财政年份:
- 资助金额:
-- - 项目类别:
ANTIVIRAL ACTIVITY OF LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES
脂质体反义寡核苷酸的抗病毒活性
- 批准号:
3748271 - 财政年份:
- 资助金额:
-- - 项目类别:
INHIBITION OF HIV REPLICATION BY NYSTATIN A AND OTHER AGENTS
制霉菌素 A 和其他药物抑制 HIV 复制
- 批准号:
3792580 - 财政年份:
- 资助金额:
-- - 项目类别:
IMMUNOLIPOSOMAL ADRIAMYCIN AS AN ANTIVIRAL AGENT IN HIV INFECTED H9 CELLS
免疫脂质体阿霉素作为 HIV 感染 H9 细胞的抗病毒剂
- 批准号:
3792601 - 财政年份:
- 资助金额:
-- - 项目类别:
EFFECT OF ANTIBODY-COMPLEMENT MEDIATED LYSIS OF HIV-2 INFECTED CELLS
抗体补体介导的 HIV-2 感染细胞裂解作用
- 批准号:
3792603 - 财政年份:
- 资助金额:
-- - 项目类别:
HIV-1 PROTEASE INHIBITOR CERULENIN AS AN ANTIVIRAL AGENT
HIV-1 蛋白酶抑制剂 Cerulenin 作为抗病毒剂
- 批准号:
3804860 - 财政年份:
- 资助金额:
-- - 项目类别:
CERULENIN AND ZN--HIV-REPLICATION INHIBITORS AS ANTIVIRAL AGENTS
浅蓝素和 ZN--HIV 复制抑制剂作为抗病毒剂
- 批准号:
5200825 - 财政年份:
- 资助金额:
-- - 项目类别:
AMPHIREGULIN AS AN AUTOCRINE GROWTH FACTOR FOR HUMAN COLON CARCINOMA CELLS
双调蛋白作为人结肠癌细胞的自分泌生长因子
- 批准号:
3792604 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
有機分子触媒を用いたAmphotericin Bの合成研究
有机分子催化剂合成两性霉素B的研究
- 批准号:
24K17671 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
EnLAmB - Enabling global access to affordable generic liposomal amphotericin B injectable formulations via advanced manufacturing technology
EnLAmB - 通过先进的制造技术,使全球能够获得负担得起的通用脂质体两性霉素 B 注射制剂
- 批准号:
MR/X014010/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Grant
Integrating genome-wide association study, quantitative trait loci mapping and transcriptome sequencing to identify genes associated with amphotericin B resistance in Aspergillus fumigatus
整合全基因组关联研究、数量性状基因座作图和转录组测序,鉴定与烟曲霉两性霉素 B 耐药性相关的基因
- 批准号:
559052-2021 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Study on naturally-occurring peptides potentiating amphotericin B activity
天然存在的肽增强两性霉素 B 活性的研究
- 批准号:
22K05333 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating genome-wide association study, quantitative trait loci mapping and transcriptome sequencing to identify genes associated with amphotericin B resistance in Aspergillus fumigatus
整合全基因组关联研究、数量性状基因座作图和转录组测序,鉴定与烟曲霉两性霉素 B 耐药性相关的基因
- 批准号:
559052-2021 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Amphotericin B Restoration of Anion Secretion in Cystic Fibrosis Airways
两性霉素 B 恢复囊性纤维化气道阴离子分泌
- 批准号:
10024667 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
9909193 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Amphotericin B Restoration of Anion Secretion in Cystic Fibrosis Airways
两性霉素 B 恢复囊性纤维化气道阴离子分泌
- 批准号:
10248529 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
10484014 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Development of NH101: A Simple and Efficient Outpatient Dry Powder Amphotericin B-DryNeb(dry powder nebulizer) for Treatment of Susceptible and Multidrug Resistant Aspergillus/ Fungal Infections
NH101的开发:一种简单高效的门诊干粉两性霉素B-DryNeb(干粉雾化器),用于治疗敏感和多重耐药曲霉菌/真菌感染
- 批准号:
10654834 - 财政年份:2020
- 资助金额:
-- - 项目类别:














{{item.name}}会员




